Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene

Citation
D. Luschow et al., Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene, VACCINE, 19(30), 2001, pp. 4249-4259
Citations number
36
Categorie Soggetti
Veterinary Medicine/Animal Health",Immunology
Journal title
VACCINE
ISSN journal
0264410X → ACNP
Volume
19
Issue
30
Year of publication
2001
Pages
4249 - 4259
Database
ISI
SICI code
0264-410X(20010720)19:30<4249:POCFLA>2.0.ZU;2-6
Abstract
The H5 hemagglutinin (HA) gene of a highly pathogenic avian influenza virus (AIV) isolate (A/chicken/Italy/8/98) was cloned and sequenced, and inserte d at the non-essential UL50 (dUTPase) gene locus of a virulent strain of in fectious laryngotracheitis virus (ILTV). Northern and Western blot analyses of the obtained ILTV recombinants demonstrated stable expression of the HA gene under control of the human cytomegalovirus immediate-early gene promo ter. In vitro replication of the HA-expressing ILTV mutants was not affecte d, and infection of chickens revealed a reduced but still considerable viru lence, similar to that of a UL50 gene deletion mutant without foreign gene insertion. The immunized animals produced specific antibodies against ILTV and AIV HA, and were protected against challenge infections with either vir ulent ILTV, or two different highly pathogenic AIV strains (A/chicken/Italy /8/98, A/chicken/Scotland/59). After challenge, no ILTV could be reisolated from protected animals, and shedding of AIV was considerably reduced. Thus , although attenuation remains to be improved, genetically engineered ILTV live-virus vaccines might be used as vectors to protect chickens also again st other pathogens. (C) 2001 Elsevier Science Ltd. All rights reserved.